Insmed (INSM) Misses Q4 EPS by 1c, Revenues Beat; Provides FY20 Sales Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| INSMED (NASDAQ: INSM) | Delayed: 109.31 -3.27 (2.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $112.58 | 52 Week High | $19.30 | |||
| Open | $112.68 | 52 Week Low | $9.02 | |||
| Day High | $113.05 | P/E | N/A | |||
| Day Low | $109.22 | EPS | $-1.69 | |||
| Volume | 4,241,717 | |||||
